SCHEDULE 13G

Company

REGENERON PHARMACEUTICALS, INC.

Filed

April 8, 2003

Accession Number

0001005477-03-000122

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →